The team included Christoph Neeracher (pictured), Philippe Seiler and Yves Suter (all M&A), Susanne Schreiber, Cyrill Diefenbacher and Kerim Tbaishat (all Tax), Lukas Roesler and Tim Salz (both Financing) as well as Thomas Stoltz
Tags :Susanne Schreiber
The team included Christoph Neeracher (pictured), Philippe Seiler, Isabelle Stalder and Patrick Zumsteg (all M&A), Susanne Schreiber (Tax) as well as Lukas Roesler (Financing).
Bär & Karrer acts as Swiss legal advisor to EMZ in this transaction. The team includes Christoph Neeracher (pictured), Raphael Annasohn, Raphael Egger, Yves Suter and Lukas Bründler (all M&A), Laura Widmer and
The team comprises Florian Gunz Niedermann (Partner, Corporate/M&A - pictured) and Christian Lütolf (Managing Associate, Corporate/M&A). The Walder Wyss team already advised GetYourGuide in May 2019 in its series E financing
Bär & Karrer acted as legal advisor to Valora in this transaction. The team included Thomas U. Reutter (pictured) and Alexander von Jeinsen (both Capital Markets), Michael Rohrer (Notarial Services) as well as Susanne Schreiber
Bär & Karrer acts as legal advisor to Vifor Pharma in this transaction. The team includes Christoph Neeracher (pictured), Raphael Annasohn and Lukas Bründler (all M&A), Susanne Schreiber and Elena Kumashova (both Tax),
The team included Thomas U. Reutter (pictured), Annette Weber and Fabian Wild (all Capital Markets) as well as Susanne Schreiber and Elena Kumashova (both Tax).
The team included Christoph Neeracher (pictured), Raphael Annasohn and Lukas Bründler (all M&A), Susanne Schreiber, Kerim Tbaishat and Elena Kumashova (all tax) as well as Thomas Stoltz and Michael Rohrer (both notarial services).
Bär & Karrer acts as legal advisor to Capvis in this transaction. The team includes Christoph Neeracher (pictured), Philippe Seiler, Raphael Egger and Li Wei Dutler
Polyphor AG has entered into an equity-linked financing arrangement with the French company IRIS to raise a gross amount of up to CHF 19.3 million over a period of two years. Under the financing instrument, IRIS
